Mice Model Market: Driving Innovation in Preclinical Research

The Mice Model Market plays a pivotal role in advancing biomedical research, drug discovery, and disease modeling. From genetically engineered models to disease-specific rodents, mice models have become indispensable tools for scientists worldwide. The global mice model market, valued at US$1.53 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$2.74 billion by the end of the period.

This article explores the current landscape, emerging trends, and opportunities within the mice model market, offering insights for researchers, biotech companies, and pharma stakeholders.

Introduction to Mice Models

Mice have been the cornerstone of preclinical studies due to their genetic similarity to humans, ease of breeding, and well-characterized biology. They serve as laboratory mice research models for understanding complex diseases, testing drug efficacy, and evaluating safety profiles.

Modern research relies heavily on genetically engineered mouse models (GEMMs) and CRISPR mice models to replicate human disease conditions, making them vital for precision preclinical research.

Types of Mice Models Used in Research

Researchers utilize various mice models depending on study objectives:

1. Inbred Strains

• Genetically identical mice used to minimize variability.
• Ideal for immunology and oncology research.

2. Genetically Engineered Models (GEMs)

• Created using gene editing tools like CRISPR-Cas9.
• Used to study specific genetic disorders and disease mechanisms.

3. Xenograft Models

• Human tumor or tissue is transplanted into mice.
• Crucial for oncology drug development.

4. Transgenic Mice

• Carry foreign genes inserted into their genome.
• Enable studies on gene function and therapeutic targets.

Key Drivers of the Mice Model Market

Several factors are propelling the mice model market growth:

• Increasing demand for preclinical research mice models in pharma and biotech.
• Rising adoption of AI-driven animal models for predictive analysis.
• Growth in chronic disease prevalence prompting advanced disease modeling.
• Technological advancements in precision preclinical research tools.
• Supportive regulatory environments promoting ethical animal research.

Trends Shaping the Future

Emerging trends are transforming mice-based research:

• CRISPR-Cas9 technology: Faster and more precise gene editing.
• Humanized mouse models: Better mimic human physiology for translational research.
• AI & machine learning integration: Enhances predictive modeling and study outcomes.
• High-throughput phenotyping: Speeds up drug screening and efficacy studies.
• Ethical and alternative methods: Combining in vitro models with mice studies for efficiency.

These trends indicate that the global mice model market will continue expanding, supporting drug discovery platforms and biotech research tools.

Leading Applications in Drug Discovery

Mice models are extensively used across:

• Oncology research: Tumor growth studies and drug testing.
• Neurology studies: Alzheimer’s, Parkinson’s, and psychiatric disorder modeling.
• Immunology research: Vaccine development and autoimmune disease studies.
• Metabolic disorder studies: Diabetes, obesity, and cardiovascular research.

These applications highlight the central role of rodent models in drug discovery, enhancing translational success from lab to clinic.

Top Players in the Mice Model Market

Key companies driving innovation in the mice model market include:

• Charles River Laboratories (US)
• Envigo RMS (US)
• The Jackson Laboratory (US)
• Taconic Biosciences (US)
• Crown Bioscience (China)

These organizations offer comprehensive animal model services, enabling advanced preclinical studies globally.

Summary

The Mice Model Market continues to be a cornerstone of biomedical research, driven by innovations in genetic engineering, AI integration, and humanized models. With a projected market value of US$2.74 billion by 2030, the opportunities for biotech companies, pharma researchers, and academic institutions are immense.

Whether you are looking to accelerate drug discovery platforms or enhance preclinical studies, leveraging the latest mice model technologies is crucial.

Explore advanced mice models to optimize your research outcomes and stay ahead in the competitive world of preclinical research.